Drug Profile


Latest Information Update: 07 Nov 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator SyntheMed
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Skin ulcer

Most Recent Events

  • 07 Nov 2000 No-Development-Reported for Skin ulcer in Israel (Topical)
  • 25 Jul 1997 Discontinued-III for Skin ulcer in European Union (Topical)
  • 06 Nov 1996 Phase-III clinical trials for Skin ulcer in European Union (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top